check quantity

Real-World Evidence (RWE)

Real-World Evidence (RWE) has become an integral component of drug and medical device development, as well as of Health Economics & Outcomes Research (HEOR). Serving as a complement to conventional randomized clinical trials (RCTs), Real-World Evidence collects supporting outcomes and safety data beyond RCTs, that provide a more comprehensive view of a product's real-life therapeutic and economic value to patients, payers, providers and sponsors. With the right data and analytics support, Real-World Evidence informs a common understanding of a drug or device efficacy and safety profile that is used by multiple healthcare stakeholders to drive decisions.

Please enter valid quantity

Please login to add favorites


Part Number
Buy Now

You successfully added item(s) to your cart


Our Real-World Evidence solution, leveraging TIBCO Spotfire®, accelerates time to insight with pre-built analysis modules that create the possibility to conduct an end-to-end analysis in one place:

  • Bring multiple data sources into one area
  • Assess background safety signals
  • Create relevant subsets of data for refined analysis
    (e.g., propensity matched cohorts)
  • Predictive analytics via machine learning and statistical
    methods to address:
    • Medication adherence
    • Patient outcomes
    • Comparative effectiveness
  • Archive results and work projects for easy retrieval later

Resources, Events & More

Resource Type File Name File Format
Webinars Unified Data Access & Visual Analytics for Better Medical Outcomes Webinars
White Paper Clinical Data Aggregation White Paper
White Paper Transforming Clinical Development White Paper
White Paper Real–World Evidence Through Advanced Analytics White Paper
White Paper Achieving Clinical Operations Excellence White Paper